Natural Product: NPC249404

Natural Product IDNPC249404
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
QXBAIZZDGIOKAV-SREVYHEPSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 44133540
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0000176] Benzoic acids and derivatives
          • [CHEMONTID:0001248] Hydroxybenzoic acid derivatives
            • [CHEMONTID:0000487] Salicylic acid and derivatives
              • [CHEMONTID:0002514] Salicylic acids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey QXBAIZZDGIOKAV-SREVYHEPSA-N
Standard InCHI InChI=1S/C24H38O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18-21-19-17-20-22(25)23(21)24(26)27/h6-7,17,19-20,25H,2-5,8-16,18H2,1H3,(H,26,27)/p-1/b7-6-
SMILES CCCCC/C=CCCCCCCCCCCc1cccc(c1C(=O)O)[O-]

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   374.28 Volume:   428.292
?
Van der Waals volume.
Dense:   0.874 LogP:   8.284
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.157
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.722
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   16.0 Rigid Bonds:   8.0
TPSA:   57.53
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   2.0 Rings:   1.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.236 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.327 Fsp3:   0.625
MCE-18:   7.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.634 Fluc inhibitor:   0.31
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.035
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.266
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.8 Promiscuous compounds:   0.287

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.084 MDCK Permeability:   -4.702
Pgp-inhibitor:   0.906 Pgp-substrate:   0.0
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.012
20% Bioavailability (F20%):   0.101 30% Bioavailability (F30%):   0.808
50% Bioavailability (F50%):   0.772

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.007 MRP1:   0.998
Plasma Protein Binding (PPB):   98.607% Volume Distribution (VD):   -0.514
Fu: 0.318%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.052
OATP1B3 inhibitor:   0.978 BCRP inhibitor:   0.641
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.996
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.558
CYP2C9-inhibitor:   0.994 CYP2C9-substrate:   0.006
CYP2D6-inhibitor:   0.705 CYP2D6-substrate:   0.326
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.002 CYP2C8-inhibitor:   1.0
HLM stability:   0.424
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.334 Half-life (T1/2):  1.192

ADMET: Toxicity

hERG Blockers:  0.32 hERG Blockers (10um):  0.484
Human Hepatotoxicity (H-HT):  0.275 Drug-induced Liver Injury (DILI):  0.019
AMES Toxicity:  0.09 Rat Oral Acute Toxicity:  0.094
Maximum Recommended Daily Dose:  0.113 Skin Sensitization:  1.0
Carcinogencity:  0.025 Eye Corrosion:  0.981
Eye Irritation:  0.996 Respiratory Toxicity:  0.94
Drug-induced Neurotoxicity:  0.004 Ototoxicity:  0.249
Hematotoxicity:  0.023 Drug-induced Nephrotoxicity:  0.663
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.051
A549 Cytotoxicity:  0.867 Hek293 Cytotoxicity:  0.26
BCF:   0.832
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.528
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.064
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.467
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4044 Homalomena occulta Species Araceae Eukaryota n.a. aerial part n.a. PMID[17511005]
NPO4044 Homalomena occulta Species Araceae Eukaryota n.a. rhizome n.a. PMID[18649899]
NPO4044 Homalomena occulta Species Araceae Eukaryota n.a. rhizome n.a. PMID[22573367]
NPO4044 Homalomena occulta Species Araceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO4044 Homalomena occulta Species Araceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO4044 Homalomena occulta Species Araceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO4044 Homalomena occulta Species Araceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC249404 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6182 Remote Similarity NPC244994
0.6182 Remote Similarity NPC222876
0.6182 Remote Similarity NPC292665
0.6182 Remote Similarity NPC179092
0.6 Remote Similarity NPC238531
0.6 Remote Similarity NPC178395
0.5862 Remote Similarity NPC301987
0.5818 Remote Similarity NPC483452
0.5593 Remote Similarity NPC115188
0.5593 Remote Similarity NPC159760
0.5345 Remote Similarity NPC17840
0.5345 Remote Similarity NPC247477
0.5333 Remote Similarity NPC26433
0.5246 Remote Similarity NPC167055
0.5156 Remote Similarity NPC240744
0.5091 Remote Similarity NPC483451
0.5091 Remote Similarity NPC227450
0.5091 Remote Similarity NPC272454
0.5091 Remote Similarity NPC35856
0.5091 Remote Similarity NPC609957
0.5082 Remote Similarity NPC184579
0.5082 Remote Similarity NPC233165

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC249404 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data